advertisment Advertisement
This ad will close in  seconds. Skip now
advertisment Advertisement
advertisment Advertisement
advertisment Advertisement
advertisment Advertisement

Medical Treatment Amplifiers

January 17, 2011
/ Print / Reprints /
| Share More
/ Text Size+


RFHIC introduces high efficiency Medical treatment amplifiers for Hyperthermia treatment or RF ablation applications. Up to 55% efficiency on AB class amplification.

RFHIC Corporation, manufacturer of active RF & MW components and hybrids for wireless telecommunication markets, released Hyperthermia treatment or RF ablation purpose RF amplifier. This pallet amplifier uses GaN-on-SiC technology which is very robust against back power or other damages, and reduces the need for maintenance.

Early stages of a cancer treatment often use this effective RF technology to treat patients. This highly efficient power amplifier uses 2.3-2.5 GHz frequency, and has 200 W output power, and three stage amplifier design totaling 31 dB gain. Final stage amplifier has 55% efficiency when operated at AB class amplification. When using the power amplifier on an E-class amplification, the efficiency reaches 90% efficiency.

Above photo shows the 250mm x 120mm x 30mm size of the amplifier with isolator and low pass filter (LPF). Higher power can be achieved by combining multiple pallet amplifiers. Fan inclusive designs are available as well.

“Much has been said on cancer treatment by RF technology, and many research results show hard evidence that this actually works and is better than traditional medical surgery. Recent post from Samsung Medical Center(SMC) comments that Radiofrequency ablation, or RFA, treatment has proved to be the most effective and the safest approach to destroying inoperable early-stage tumors in the liver. RFHIC is proud to support such an industry with high performance RF amplifiers” said Mr. Kevin Kim, Senior International Sales Manager, RFHIC Corporation.

Samsung Medical Center(SMC) announced that the RFA treatment team has demonstrated a remarkable success rate across 3,600 cases of liver cancer patients for the ten years from April 1999 to April 2009. The team performed RFA treatment 3,594 times on 2,600 patients over a 10-year period.

RFMA245 is available in sample quantity immediately. Other higher output, or custom medical amplifier designs are available from RFHIC as well. For additional information regarding RFHIC’s products, visit www.rfhic.com or contact rfsales@rfhic.com, (Tel:82-31-250-5011).

Post a comment to this article

Sign-In

Forgot your password?

No Account? Sign Up!

Get access to premium content and e-newsletters by registering on the web site.  You can also subscribe to Microwave Journal magazine.

Sign-Up

advertisment Advertisement